CN102670708A - Chinese medicinal oral liquid for treating migraine and preparation method thereof - Google Patents

Chinese medicinal oral liquid for treating migraine and preparation method thereof Download PDF

Info

Publication number
CN102670708A
CN102670708A CN201210185539XA CN201210185539A CN102670708A CN 102670708 A CN102670708 A CN 102670708A CN 201210185539X A CN201210185539X A CN 201210185539XA CN 201210185539 A CN201210185539 A CN 201210185539A CN 102670708 A CN102670708 A CN 102670708A
Authority
CN
China
Prior art keywords
parts
oral liquid
herba
chinese medicine
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210185539XA
Other languages
Chinese (zh)
Inventor
黄芸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210185539XA priority Critical patent/CN102670708A/en
Publication of CN102670708A publication Critical patent/CN102670708A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese medicinal oral liquid for treating migraine. The Chinese medicinal oral liquid is prepared from the following bulk pharmaceuticals in parts by weight: 100-200 parts of mint, 100-200 parts of chrysanthemum, 400-500 parts of pseudo-ginseng root, 250-350 parts of Korean ginseng, 250-350 parts of szechuan lovage rhizome and 100-200 parts of wild ginger. The oral liquid disclosed by the invention can be used for quickly treating symptoms such as severe pulsatile headache, nausea and vomit caused by migraine, and has a special treatment effect on migraine and a remarkable curative effect.

Description

Treat migrainous Chinese medicine oral liquid and method for preparing
Technical field
The invention belongs to the field of Chinese medicines, migrainous Chinese medicine oral liquid of particularly a kind of treatment and method for preparing.
Background technology
Migraine is to be clinical comprehensive the combining of characteristics with the head vasomotor dysfunction, and female patient is more than the male, and clinical manifestation generally continues several hours for kind severe headache of periodically beating, often with dizzy, the nausea etc. of feeling sick.The few patients premorbid can happen suddenly dim eyesight, teichopsia or Venus, to look thing damaged etc.Much human is thought indisposition, and generally speaking, headache or Body Position Change and have a headache and do not have too big problem should have not big harm once in a while.Headache for a long time or frequent headache but,, just should draw attention, because possibly be the tendencys of severe disease if long-time dizzy.Chinese medicine is used to treat migrainous medicine, owing to have little, the eutherapeutic characteristics of side effect, so favored by people.
Summary of the invention
The object of the present invention is to provide little, the good effect of a kind of side effect, be used to treat migrainous Chinese medicine oral liquid and method for preparing.
For realizing above-mentioned purpose, the present invention realizes through following technical scheme:
Treating migrainous Chinese medicine oral liquid, is to be processed by the crude drug of following parts by weight:
Herba Menthae 100-200 part, Flos Chrysanthemi 100-200 part, Radix Notoginseng 400-500 part, Korean Ginseng 250-350 part, Rhizoma Chuanxiong 250-350 part, Herba Asari 100-200 part.
The migrainous Chinese medicine oral liquid of described treatment is to be processed by the crude drug of following parts by weight:
150 parts of Herba Menthaes, 150 parts of Flos Chrysanthemis, 450 parts of Radix Notoginseng, 300 parts of Korean Ginseng, 300 parts of Rhizoma Chuanxiongs, 150 parts of Herba Asaris.
Migrainous Chinese medicine oral liquid of described treatment and method for preparing comprise the following steps:
Get it filled 150 parts of material Herba Menthaes, 150 parts of Flos Chrysanthemis, 450 parts of Radix Notoginseng, 300 parts of Korean Ginseng, 300 parts of Rhizoma Chuanxiongs, 150 parts of Herba Asaris, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each 1-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, leave standstill, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Instructions of taking: every day 3 times, a dose is 15ml, and 10 days one courses of treatment, the back of taking medicine is many took effect at 1-5 days, cured in 1-5 days.This Chinese medicine oral liquid characteristics are that the patient is fully recovered, instant effect, and effective, toxic and side effects is little, plays treating both the principal and secondary aspects of a disease, sets upright evil, the eliminating evil positive effect of not hindering that do not stagnate, and does not have recurrence, and cost is low, is worth clinical application.
In the raw material of Chinese medicine that the present invention selected for use, Herba Menthae: hot, cool, return lung, Liver Channel, dispelling wind and heat pathogens, the clear sharp head, sore-throat relieving, rash, dispersing the stagnated live-QI to relieve the stagnation of QI; Flos Chrysanthemi: hot, sweet, bitter, little Huang, return lung, Liver Channel, dispelling wind and heat pathogens, suppressing the hyperactive liver make eye bright, heat-clearing and toxic substances removing; Radix Notoginseng: sweet, little hardship, temperature, GUIXIN, liver, spleen channel, removing stasis to stop bleeding, the analgesic therapy of invigorating blood circulation; Korean Ginseng: sweet, little hardship, tepor, go into spleen, lung meridian, strongly invigorating primordial QI, multiple arteries and veins take off admittedly, invigorating the spleen to benefit the lung, promoting the production of body fluid to quench thirst, the Fructus Alpiniae Oxyphyllae of calming the nerves; Rhizoma Chuanxiong: hot, warm, return liver, gallbladder, pericardium channel, blood-activating and qi-promoting, the stasis of blood of dispeling the wind pain relieving; Herba Asari: hot, warm, return lung, kidney channel, expelling wind and cold, sensible, pain relieving, warming the lung to resolve fluid-retention; All medicines are harmonious, and play the soothing liver-QI circulation of qi promoting altogether, the merit of promoting blood circulation and stopping pain.The irritability bar is reached, unobstructed vessel, the Wei Zihe of battalion, pain is ended and cold and heat also remove.Oral liquid of the present invention rapidly the violent pulsatile headache due to the migraine, feel sick, the symptom of vomiting, specially medicine is specially controlled, and is evident in efficacy.Points for attention: anemia of pregnant woman's forbidding.
The specific embodiment
Embodiment 1:
Crude drug: 150 parts of Herba Menthaes, 150 parts of Flos Chrysanthemis, 450 parts of Radix Notoginseng, 300 parts of Korean Ginseng, 300 parts of Rhizoma Chuanxiongs, 150 parts of Herba Asaris.
Method for making; Get it filled 150 parts of material Herba Menthaes, 150 parts of Flos Chrysanthemis, 450 parts of Radix Notoginseng, 300 parts of Korean Ginseng, 300 parts of Rhizoma Chuanxiongs, 150 parts of Herba Asaris, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each 1-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, leave standstill, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Embodiment 2:
Crude drug: 200 parts of Herba Menthaes, 200 parts of Flos Chrysanthemis, 500 parts of Radix Notoginseng, 350 parts of Korean Ginseng, 350 parts of Rhizoma Chuanxiongs, 200 parts of Herba Asaris.
Method for making; Get it filled 200 parts of material Herba Menthaes, 200 parts of Flos Chrysanthemis, 500 parts of Radix Notoginseng, 350 parts of Korean Ginseng, 350 parts of Rhizoma Chuanxiongs, 200 parts of Herba Asaris, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each 1-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, leave standstill, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Embodiment 3:
Crude drug: 100 parts of Herba Menthaes, 100 parts of Flos Chrysanthemis, 400 parts of Radix Notoginseng, 250 parts of Korean Ginseng, 250 parts of Rhizoma Chuanxiongs, 100 parts of Herba Asaris.
Method for making; Get it filled 100 parts of material Herba Menthaes, 100 parts of Flos Chrysanthemis, 400 parts of Radix Notoginseng, 250 parts of Korean Ginseng, 250 parts of Rhizoma Chuanxiongs, 100 parts of Herba Asaris, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each 1-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, leave standstill, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Embodiment 4:
1) clinical trial:
Male 20 examples of migraineur's 53 examples, women 33 examples; Age 43-69 year, 50 years old mean age; Course of disease 2-10.
2) Therapeutic Method: take embodiment 1 Chinese medicine oral liquid, every day 3 times, a dose is 15ml, 10 days one courses of treatment.
3) criterion of therapeutical effect: judge whether mainly be dependent on cephalagra disappears, concrete curative effect is divided following three grades:
Cure: cephalagra all disappears;
Take a turn for the better: cephalagra obviously alleviates;
Invalid: after medication 1 course of treatment, cephalagra has no to disappear.
4) therapeutic outcome: produce effects 37 examples in 53 examples account for 69.8%; Effective 13 examples account for 24.5%; Invalid 3 examples account for 5.6%; Total effective rate 94.3%.All more than the equal follow-up observation of case half a year, the longest 1 example is followed up a case by regular visits to and is reached 7 years.Late result is: produce effects 30 examples account for 60%; Effective 12 examples account for 22.6%; Invalid 11 examples account for 20.7%; Total effective rate 79.2%.
Embodiment 5:
Model case: journey, the woman, 38 years old, the main suit violated migraine after existing February; Getting up morning, the back is dizzy, order is stuck with paste, and constant pain reaches 2-3 hours every day, and si dol urg is also accompanied nauseating, takes embodiment 1 Chinese medicine oral liquid; Clothes are 5 earlier, and symptom is clearly better, and continue and obey 5; Recovery from illness was visited after 3 months, did not see recurrence.
Embodiment 6:
Model case: sternly certain, the man, 50 years old, main suit's migraine had half a year; Dizzy, order is stuck with paste, and dull pain appears in the right side temple, diffuses to a whole side then, and si dol urg is also accompanied nauseating; Take embodiment 1 Chinese medicine oral liquid, obeyed 10, symptom is clearly better, and clothes recovery from illness on the 10th continues; The symptom complete obiteration, recovery from illness was visited after 3 months, did not see recurrence.

Claims (3)

1. treat migrainous Chinese medicine oral liquid, it is characterized in that: be to process by the crude drug of following parts by weight:
Herba Menthae 100-200 part, Flos Chrysanthemi 100-200 part, Radix Notoginseng 400-500 part, Korean Ginseng 250-350 part, Rhizoma Chuanxiong 250-350 part, Herba Asari 100-200 part.
2. the migrainous Chinese medicine oral liquid of treatment according to claim 1 is characterized in that: be to be processed by the crude drug of following parts by weight:
150 parts of Herba Menthaes, 150 parts of Flos Chrysanthemis, 450 parts of Radix Notoginseng, 300 parts of Korean Ginseng, 300 parts of Rhizoma Chuanxiongs, 150 parts of Herba Asaris.
3. migrainous Chinese medicine oral liquid of treatment according to claim 1 and method for preparing is characterized in that: comprise the following steps:
Get it filled 150 parts of material Herba Menthaes, 150 parts of Flos Chrysanthemis, 450 parts of Radix Notoginseng, 300 parts of Korean Ginseng, 300 parts of Rhizoma Chuanxiongs, 150 parts of Herba Asaris, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each 1-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, leave standstill, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
CN201210185539XA 2012-06-06 2012-06-06 Chinese medicinal oral liquid for treating migraine and preparation method thereof Pending CN102670708A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210185539XA CN102670708A (en) 2012-06-06 2012-06-06 Chinese medicinal oral liquid for treating migraine and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210185539XA CN102670708A (en) 2012-06-06 2012-06-06 Chinese medicinal oral liquid for treating migraine and preparation method thereof

Publications (1)

Publication Number Publication Date
CN102670708A true CN102670708A (en) 2012-09-19

Family

ID=46803694

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210185539XA Pending CN102670708A (en) 2012-06-06 2012-06-06 Chinese medicinal oral liquid for treating migraine and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102670708A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104547645A (en) * 2015-01-21 2015-04-29 贵阳名草堂绿色植物科技开发中心 Liniment for treating migraine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1778362A (en) * 2004-11-25 2006-05-31 杨万里 Formula for treating wind heat and headache
CN101983717A (en) * 2010-10-08 2011-03-09 刘树彬 Traditional Chinese medicine for treating migraine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1778362A (en) * 2004-11-25 2006-05-31 杨万里 Formula for treating wind heat and headache
CN101983717A (en) * 2010-10-08 2011-03-09 刘树彬 Traditional Chinese medicine for treating migraine

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
丁爱国: "韩子江以治偏灵治疗偏头痛的经验", 《山东中医杂志》, vol. 16, no. 02, 28 February 1997 (1997-02-28), pages 85 - 86 *
吴玉生等: "《常见病中医处方手册》", 31 August 2011, article "川芎茶调散", pages: 170-171 *
国家药典委员会: "《中华人民共和国药典 2010年版 一部》", 31 January 2010, article "通天口服液", pages: 1049-1050 *
张觉人等: "偏头痛中医药研究述要", 《中医药临床杂志》, vol. 18, no. 01, 28 February 2006 (2006-02-28), pages 93 - 94 *
石旭星等: "中西医结合治疗偏头痛70例", 《实用医技杂志》, vol. 14, no. 25, 30 September 2007 (2007-09-30), pages 3493 - 3494 *
陈鸿: "《现代居家实用手册》", 31 July 1998, article "高丽参三七丸", pages: 181-182 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104547645A (en) * 2015-01-21 2015-04-29 贵阳名草堂绿色植物科技开发中心 Liniment for treating migraine

Similar Documents

Publication Publication Date Title
CN102895501A (en) Drug for the treatment of insomnia
CN102397376B (en) Chinese medicinal composition for treating dysmenorrhea and compound supercritical fluid extract
CN104083438A (en) Balsam pear-containing traditional Chinese medicinal preparation for alleviating hypertension, and preparation method thereof
CN104127702A (en) Traditional Chinese medicine preparation for treating acute optic neuritis, as well as preparation method thereof
CN102698091B (en) Traditional Chinese medicine oral liquid for relieving neurasthenia and preparation method
CN102697911A (en) Traditional Chinese medicine composition for treating insomnia
CN105343660A (en) Traditional Chinese medicinal preparation for treating peripheral vertigo and preparation method of traditional Chinese medicinal preparation
CN102600351B (en) Traditional Chinese medicine for treating pruritus cutanea
CN102670708A (en) Chinese medicinal oral liquid for treating migraine and preparation method thereof
CN102846113A (en) Mulberry leaf health care pillow core and preparation method thereof
CN104324205A (en) Traditional Chinese medicine composition for treating heart diseases
CN102670743B (en) Lotus leaf-silkworm excrement Chinese medicinal oral liquid for treating headache and preparation method thereof
CN102688365B (en) Ginkgo Chinese medicinal oral liquid for treating dizziness and preparation method thereof
CN105232791A (en) Traditional Chinese medicine for treating migraine in neurology department
CN102670737B (en) Traditional Chinese medicine oral liquid for relieving iron deficiency anemia and preparation method thereof
CN101607007B (en) Traditional Chinese medicine preparation for treating cerebral circulation insufficiency
CN102178851B (en) Medicament for treating nervous headache
CN103893598A (en) Traditional Chinese medicine for treating insomnia
CN104840551A (en) Hypertension relieving mulberry leaf Chinese medicine preparation and preparing method
CN102670714B (en) Semen raphani Chinese medicine oral liquid for relieving high blood pressure and preparation method of same
CN102688399B (en) Mother chrysanthemum traditional Chinese medicine oral liquid for treating dizziness and preparation method for oral liquid
CN103893470A (en) Chinese medicine composition for treating malar rash
CN104257849A (en) Traditional Chinese medicine for treating cardiovascular diseases
CN103127400B (en) Drug for treatment of anxiety disorder and preparation method thereof
CN103977273A (en) Drug for treating cerebral concussion sequelae

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120919